These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35704945)
1. Endothelin system expression in the kidney following cisplatin-induced acute kidney injury in male and female mice. Gales A; Monteiro-Pai S; Hyndman KA Can J Physiol Pharmacol; 2022 Sep; 100(9):868-879. PubMed ID: 35704945 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase expression following cisplatin-induced acute kidney injury in male and female mice. Nguyen H; Gales A; Monteiro-Pai S; Oliver AS; Harris N; Montgomery AD; Franzén S; Kasztan M; Hyndman KA Am J Physiol Renal Physiol; 2024 Oct; 327(4):F623-F636. PubMed ID: 39116350 [TBL] [Abstract][Full Text] [Related]
4. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer. Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568 [TBL] [Abstract][Full Text] [Related]
5. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation. Yang C; Guo Y; Huang TS; Zhao J; Huang XJ; Tang HX; An N; Pan Q; Xu YZ; Liu HF Biomed Pharmacother; 2018 Nov; 107():1354-1362. PubMed ID: 30257350 [TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2. Yang Y; Liu S; Gao H; Wang P; Zhang Y; Zhang A; Jia Z; Huang S Free Radic Biol Med; 2020 May; 152():821-837. PubMed ID: 32004633 [TBL] [Abstract][Full Text] [Related]
7. Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway. Xie KH; Liu XH; Jia J; Zhong X; Han RY; Tan RZ; Wang L Int Immunopharmacol; 2022 Nov; 112():109247. PubMed ID: 36155281 [TBL] [Abstract][Full Text] [Related]
8. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway. Yang SK; Han YC; He JR; Yang M; Zhang W; Zhan M; Li AM; Li L; Na-Song ; Liu YT; Wu XQ; Zhang Q; Wang JW; Zhang H Biomed Pharmacother; 2020 Oct; 130():110521. PubMed ID: 32717631 [TBL] [Abstract][Full Text] [Related]
9. Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury. Wei H; Gou W; Gao J; Ning H; Song Y; Li D; Qin Y; Hou W; Li Y Eur J Med Chem; 2022 Feb; 230():114115. PubMed ID: 35033824 [TBL] [Abstract][Full Text] [Related]
10. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Hu Z; Zhang H; Yi B; Yang S; Liu J; Hu J; Wang J; Cao K; Zhang W Cell Death Dis; 2020 Jan; 11(1):73. PubMed ID: 31996668 [TBL] [Abstract][Full Text] [Related]
11. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation. Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA expression profiles in cisplatin-induced acute kidney injury in mice. Li CM; Li M; Ye ZC; Huang JY; Li Y; Yao ZY; Peng H; Lou TQ Epigenomics; 2019 Aug; 11(10):1191-1207. PubMed ID: 31339054 [No Abstract] [Full Text] [Related]
13. TSC1 deletion in fibroblasts alleviates lipopolysaccharide-induced acute kidney injury. Shen J; Cui ZK; Yao F; Li K; Zhang Y; Chen Z; Zhou Y; Xu S; Zhang Y; Jiang W; Zhang H; Tan K; Liu A; Bai X Clin Sci (Lond); 2018 Oct; 132(19):2087-2101. PubMed ID: 30185506 [TBL] [Abstract][Full Text] [Related]
14. The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury. Kim HJ; Ravichandran K; Ozkok A; Wang Q; He Z; Jani A; Ljubanovic D; Douglas IS; Edelstein CL J Pharmacol Exp Ther; 2014 Jun; 349(3):518-25. PubMed ID: 24727856 [TBL] [Abstract][Full Text] [Related]
15. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m Zhou P; Wu M; Ye C; Xu Q; Wang L J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283 [TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury. Kim HJ; Lee DW; Ravichandran K; O Keys D; Akcay A; Nguyen Q; He Z; Jani A; Ljubanovic D; Edelstein CL J Pharmacol Exp Ther; 2013 Sep; 346(3):465-72. PubMed ID: 23833276 [TBL] [Abstract][Full Text] [Related]
17. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532 [TBL] [Abstract][Full Text] [Related]
18. IL-33 exacerbates acute kidney injury. Akcay A; Nguyen Q; He Z; Turkmen K; Won Lee D; Hernando AA; Altmann C; Toker A; Pacic A; Ljubanovic DG; Jani A; Faubel S; Edelstein CL J Am Soc Nephrol; 2011 Nov; 22(11):2057-67. PubMed ID: 21949094 [TBL] [Abstract][Full Text] [Related]
19. Bioactive peptide apelin rescues acute kidney injury by protecting the function of renal tubular mitochondria. Guan YM; Diao ZL; Huang HD; Zheng JF; Zhang QD; Wang LY; Liu WH Amino Acids; 2021 Aug; 53(8):1229-1240. PubMed ID: 34254213 [TBL] [Abstract][Full Text] [Related]
20. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury. Chen CL; Liao JW; Hu OY; Pao LH Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]